Laser facilitated epicutaneous peptide immunization using dry patch technology

Vaccine. 2021 Aug 31;39(37):5259-5264. doi: 10.1016/j.vaccine.2021.07.083. Epub 2021 Aug 4.

Abstract

The skin has been intensely investigated as a target tissue for immunization because it is populated by multiple types of antigen presenting cells. Directly addressing dendritic cells or Langerhans cells in vivo represents an attractive strategy for inducing T cell responses in cancer immunotherapy. We and others have studied fractional laser ablation as a novel method combining efficient delivery of macromolecules to the skin with an inherent adjuvant effect of laser illumination. In this proof of concept study, we demonstrate the feasibility of peptide delivery to the skin using the P.L.E.A.S.E. professional Erb:YAG fractional infrared laser together with EPIMMUN patches. In an ovalbumin mouse model we demonstrate that a dry patch formulation of SIINFEKL peptide in combination with CpG-ODN1826, but not imiquimod or polyI:C, induces potent cytotoxic T cell responses, which can be further boosted by co-delivery of the pan-helper T cell epitope PADRE.

Keywords: CTL; Epicutaneous immunization; Laser; Ovalbumin; Skin micropores.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Immunization
  • Langerhans Cells
  • Lasers*
  • Mice
  • Skin*
  • Technology